Eden Research plc - Eden and Corteva seek to bring Ecovelex to market
As the information in this release pertains to EDEN RESEARCH PLC, this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "
|
|
|
Eden Research plc and Corteva Agriscience Seek to Bring Ecovelex™ to EU and
The seed treatment product helps farmers safely repel birds
Developed by Corteva Agriscience and Eden over three years, Ecovelex represents a new entrant into the seed treatment market and is intended to replace conventional chemicals banned in the EU and
Ecovelex works by affecting the bird's olfactory system, creating an unpleasant taste or odour that repels the birds, leaving the seeds safely intact and the birds unaffected and free to find alternative food sources.
The product is based on plant-derived chemistry and formulated using Eden's Sustaine® microencapsulation system, supporting farmers as they strive to meet consumer demands for more sustainable agriculture.
"The solution we have developed with Eden offers farmers an effective and safe alternative whilst representing a huge step forward in sustainability by using plant chemistry. Eden's team has done an excellent job of helping us tackle this tremendous market opportunity, and we look forward to expanding upon this work in the future."
"Together, we are bringing another safe and effective seed treatment to market in near record time through efficient, open collaboration and a real 'win-win' approach. We will enjoy the rewards of this successful collaboration jointly, but it is the farmers who will also win as we will be providing them with a new tool for improving crop yields, safely and sustainably."
Eden has submitted the dossier and application to
In addition to their work on Ecovelex, Corteva Agriscience and Eden have been engaged in widespread collaborations including on the appointment of Corteva as Eden's distribution partner in

For further information contact:
|
Eden Research plc |
|
|
|
+44 (0) 1285 359 555
|
|
|
|
|
Cenkos Securities plc (NOMAD and broker to Eden Research plc) |
|
|
|
+44 (0) 20 7397 8900 |
|
|
|
|
Hawthorn Advisors (Financial PR to Eden Research plc) |
|
|
|
|
|
Corteva Media Enquiries |
|
|
József Máté, Corporate Communications Leader, EMEA
|
jozsef.mate@corteva.com +41 79 597 2709 |
Notes to Editors:
About Eden
Eden is the only
For more information, please visit: www.edenresearch.com.
Follow Eden on LinkedIn, Twitter and YouTube.
About Corteva
Corteva, Inc. (NYSE: CTVA) is a publicly traded, global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational execution to profitably deliver solutions for the world's most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfils its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com.
Follow Corteva on Facebook, Instagram, LinkedIn, Twitter and YouTube.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE
